Gujarat Themis Biosyn Limited (BOM:506879)
India
· Delayed Price · Currency is INR 304.80
-10.65 (-3.38%)
At close: Apr 22, 2025
Gujarat Themis Biosyn Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 1,551 | 1,698 | 1,484 | 1,149 | 905.63 | 851.24 | Upgrade
|
| Revenue Growth (YoY) | -0.77% | 14.45% | 29.20% | 26.82% | 6.39% | 107.37% | Upgrade
|
| Cost of Revenue | 607.43 | 687.4 | 573.39 | 181.25 | 168.27 | 126.2 | Upgrade
|
| Gross Profit | 943.32 | 1,011 | 910.46 | 967.29 | 737.36 | 725.05 | Upgrade
|
| Selling, General & Admin | 126.74 | 117.92 | 94.48 | 71.99 | 74.2 | 65.86 | Upgrade
|
| Other Operating Expenses | 79.24 | 105.57 | 70.99 | 307.64 | 249.14 | 340.14 | Upgrade
|
| Operating Expenses | 256.7 | 258.85 | 191.22 | 401.96 | 340.66 | 419.62 | Upgrade
|
| Operating Income | 686.63 | 751.97 | 719.25 | 565.33 | 396.7 | 305.43 | Upgrade
|
| Interest Expense | -4.13 | -2.75 | -0.95 | -6.56 | -5.25 | -2.96 | Upgrade
|
| Interest & Investment Income | 40.35 | 40.35 | 51.29 | 32.61 | 21.51 | 7.56 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 0.09 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -18.85 | 3.77 | 5.06 | -1.13 | -4.26 | 2.53 | Upgrade
|
| EBT Excluding Unusual Items | 703.99 | 793.34 | 774.65 | 590.35 | 408.7 | 312.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.12 | - | Upgrade
|
| Pretax Income | 703.99 | 793.34 | 774.65 | 590.35 | 408.82 | 312.57 | Upgrade
|
| Income Tax Expense | 177.4 | 201.71 | 194.96 | 154.1 | 107.02 | 75.82 | Upgrade
|
| Net Income | 526.59 | 591.63 | 579.69 | 436.24 | 301.8 | 236.75 | Upgrade
|
| Net Income to Common | 526.59 | 591.63 | 579.69 | 436.24 | 301.8 | 236.75 | Upgrade
|
| Net Income Growth | -4.20% | 2.06% | 32.88% | 44.55% | 27.48% | 269.40% | Upgrade
|
| Shares Outstanding (Basic) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade
|
| Shares Outstanding (Diluted) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade
|
| EPS (Basic) | 4.83 | 5.43 | 5.32 | 4.00 | 2.77 | 2.17 | Upgrade
|
| EPS (Diluted) | 4.83 | 5.43 | 5.32 | 4.00 | 2.77 | 2.17 | Upgrade
|
| EPS Growth | -4.36% | 2.01% | 32.88% | 44.57% | 27.46% | 269.50% | Upgrade
|
| Free Cash Flow | - | -104.32 | 157.74 | 264.16 | 74.73 | -26.08 | Upgrade
|
| Free Cash Flow Per Share | - | -0.96 | 1.45 | 2.42 | 0.69 | -0.24 | Upgrade
|
| Dividend Per Share | 0.167 | 0.667 | 0.720 | 0.800 | - | 0.220 | Upgrade
|
| Dividend Growth | -73.68% | -7.40% | -10.00% | - | - | - | Upgrade
|
| Gross Margin | 60.83% | 59.52% | 61.36% | 84.22% | 81.42% | 85.17% | Upgrade
|
| Operating Margin | 44.28% | 44.28% | 48.47% | 49.22% | 43.80% | 35.88% | Upgrade
|
| Profit Margin | 33.96% | 34.84% | 39.07% | 37.98% | 33.32% | 27.81% | Upgrade
|
| Free Cash Flow Margin | - | -6.14% | 10.63% | 23.00% | 8.25% | -3.06% | Upgrade
|
| EBITDA | 714.66 | 775.8 | 737.48 | 580.14 | 414.03 | 319.05 | Upgrade
|
| EBITDA Margin | 46.09% | 45.68% | 49.70% | 50.51% | 45.72% | 37.48% | Upgrade
|
| D&A For EBITDA | 28.03 | 23.83 | 18.24 | 14.81 | 17.33 | 13.62 | Upgrade
|
| EBIT | 686.63 | 751.97 | 719.25 | 565.33 | 396.7 | 305.43 | Upgrade
|
| EBIT Margin | 44.28% | 44.28% | 48.47% | 49.22% | 43.80% | 35.88% | Upgrade
|
| Effective Tax Rate | 25.20% | 25.42% | 25.17% | 26.10% | 26.18% | 24.26% | Upgrade
|
| Revenue as Reported | 1,572 | 1,742 | 1,550 | 1,189 | 938.29 | 868.29 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.